These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33535821)

  • 1. Clinical trials in a COVID-19 pandemic: Shared infrastructure for continuous learning in a rapidly changing landscape.
    Hedlin H; Garcia A; Weng Y; He Z; Sundaram V; Bunning B; Balasubramanian V; Cunanan K; Kapphahn K; Gummidipundi S; Purington N; Boulos M; Desai M
    Clin Trials; 2021 Jun; 18(3):324-334. PubMed ID: 33535821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. It is unprecedented: trial management during the COVID-19 pandemic and beyond.
    Mitchell EJ; Ahmed K; Breeman S; Cotton S; Constable L; Ferry G; Goodman K; Hickey H; Meakin G; Mironov K; Quann N; Wakefield N; McDonald A
    Trials; 2020 Sep; 21(1):784. PubMed ID: 32917258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly efficient clinical trial designs for reliable screening of under-performing treatments: Application to the COVID-19 Pandemic.
    Piantadosi S
    Clin Trials; 2020 Oct; 17(5):483-490. PubMed ID: 32666816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An example of Clinical Investigations Center reorganization during the COVID-19 pandemic French national lockdown].
    Ghrieb Z; Allaoua S; Huang J; Langner N; François F; Maréchal C; Jebali M; Lebbé C; Chellah A; Bergeron A; Kiladjian JJ; Daltro De Oliveira R; Soret-Dulphy J; Benajiba L
    Therapie; 2021; 76(4):347-358. PubMed ID: 33640116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis.
    Mehta HB; Ehrhardt S; Moore TJ; Segal JB; Alexander GC
    BMJ Open; 2020 Jun; 10(6):e039978. PubMed ID: 32518212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platform trials to evaluate the benefit-risk of COVID-19 therapeutics: Successes, learnings, and recommendations for future pandemics.
    Buenconsejo J; Liao R; Lin J; Singh P; Cooner F; Ghosh S; Gamalo M; Russek-Cohen E; Zariffa N
    Contemp Clin Trials; 2023 Sep; 132():107292. PubMed ID: 37454729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings.
    Noor NM; Pett SL; Esmail H; Crook AM; Vale CL; Sydes MR; Parmar MKB
    F1000Res; 2020; 9():1109. PubMed ID: 33149899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving effective informed oversight by DMCs in COVID clinical trials.
    DeMets DL; Fleming TR
    J Clin Epidemiol; 2020 Oct; 126():167-171. PubMed ID: 32659363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The time is now: role of pragmatic clinical trials in guiding response to global pandemics.
    Almufleh A; Joseph J
    Trials; 2021 Mar; 22(1):229. PubMed ID: 33761968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
    Jeon J; Kim H; Yu KS
    J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of platform trials in the COVID-19 pandemic: A rapid review.
    Vanderbeek AM; Bliss JM; Yin Z; Yap C
    Contemp Clin Trials; 2022 Jan; 112():106625. PubMed ID: 34793985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing Clinical Trials for Alzheimer's Disease During the COVID-19 Crisis: Experience at Fundació ACE in Barcelona, Spain.
    Abdelnour C; Esteban de Antonio E; Pérez-Cordón A; Lafuente A; Buendía M; Pancho A; Jofresa S; Aguilera N; Ibarria M; Cuevas R; Cañada L; Calvet A; Diego S; González-Pérez A; Orellana A; Montrreal L; de Jorge L; Marquié M; Benaque A; Gurruchaga M; Tárraga L; Ruiz A; Boada M;
    J Alzheimers Dis; 2020; 77(4):1805-1813. PubMed ID: 32986671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations on the clinical development of COVID-19 vaccine from trial design perspectives.
    Jiang Z; Wang X; Xia J
    Hum Vaccin Immunother; 2021 Mar; 17(3):656-660. PubMed ID: 32991223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The COVID-19 Outpatient Pragmatic Platform Study (COPPS): Study design of a multi-center pragmatic platform trial.
    Bunning B; Hedlin H; Purington N; Sundaram V; Kapphahn K; Weng Y; Cunanan K; Maldonado Y; Singh U; Khosla C; O'Hara R; Nicolls M; Springman E; Parsonnet J; Rogers A; Levitt J; Desai M
    Contemp Clin Trials; 2021 Sep; 108():106509. PubMed ID: 34274494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Trial Data Sharing for COVID-19-Related Research.
    Dron L; Dillman A; Zoratti MJ; Haggstrom J; Mills EJ; Park JJH
    J Med Internet Res; 2021 Mar; 23(3):e26718. PubMed ID: 33684053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid Adaptation of a Surgical Research Unit to Conduct Clinical Trials During the COVID-19 Pandemic.
    Emamaullee J; Bowdish M; Yan PY; Rodina V; Sher LS
    J Surg Res; 2020 Dec; 256():76-82. PubMed ID: 32683060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data monitoring committees for clinical trials evaluating treatments of COVID-19.
    Mütze T; Friede T
    Contemp Clin Trials; 2020 Nov; 98():106154. PubMed ID: 32961361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
    Anker SD; Butler J; Khan MS; Abraham WT; Bauersachs J; Bocchi E; Bozkurt B; Braunwald E; Chopra VK; Cleland JG; Ezekowitz J; Filippatos G; Friede T; Hernandez AF; Lam CSP; Lindenfeld J; McMurray JJV; Mehra M; Metra M; Packer M; Pieske B; Pocock SJ; Ponikowski P; Rosano GMC; Teerlink JR; Tsutsui H; Van Veldhuisen DJ; Verma S; Voors AA; Wittes J; Zannad F; Zhang J; Seferovic P; Coats AJS
    Eur Heart J; 2020 Jun; 41(22):2109-2117. PubMed ID: 32498081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.